Tissue Engineered Skin Substitutes Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Tissue Engineered Skin Substitutes Market Analysis
The Tissue Engineered Skin Substitute market studied is anticipated to grow with a CAGR of nearly 5.2%, during the forecast period.
Certain factors that are driving the market growth include increasing prevalence of chronic wounds, growing burn & trauma cases, and rising focus on technological advancements.
There is also a demand for relatively cheap and available skin-replacement products that have encouraged many research groups worldwide to focus on creating biomaterials for skin substitution. The engineered tissues not only closes wounds but also stimulates the regeneration of the dermis and would provide a significant benefit in human wound healing. Moreover, the increasing prevalence of chronic diseases alongside road accidents, injuries, and trauma cases escalates the market on the global platform.
There is also an increase in funding from government and private companies for R&D of regenerative treatments and growth in the adoption of the regenerative medicine industry that is expected to drive the overall market.
Tissue Engineered Skin Substitutes Market Trends
This section covers the major market trends shaping the Tissue Engineered Skin Substitute Market according to our research experts:
Chronic Wound Holds Significant Share in the Global Tissue Engineered Skin Substitute Market
The growing prevalence of several lifestyle disorders leading to chronic wounds, such as diabetic foot ulcer, venous leg ulcer, and pressure ulcer is one of the key factors estimated to encourage the growth of the tissue engineered skin substitute market in the coming years. Diabetes is found to be the major wound causing disease along with other chronic diseases.
There has been a tremendous increase in the diabetic population, across the globe, over the past decade. Several reports and surveys documented drastic increase in the diabetic population, based on the changing life style and habits. For instance, according to the British Diabetic Association, it is estimated that almost 3.7 million people are living with diabetes in the United Kingdom and the number has doubled in the past two decades. Moreover, around 12.3 million people are at an increased risk of Type 2 diabetes in the United Kingdom, and obesity is the leading cause in the majority of preventable cases.
In adults who are aged over 65 years, the population suffering from diabetes is more than 25%. The incidence of chronic wounds, especially foot ulcers is increasing among the diabetic population. While more than 80,000 adults are expected to undergo a lower extremity amputation, it is also estimated that patients with diabetes are 10 times more likely to undergo amputation at some point in their life.
North America Dominates the Global Tissue Engineered Skin Substitute Market
North America dominates the tissue engineered skin substitute market due to the increasing incidence of chronic wounds, favorable reimbursement policies, and rise in the ageing population. People with diabetes need proper and effective therapeutics, and hence the demand for incretin-based drugs is observing a significant rise across the region.
In Canada, the prevalence of diabetes among adults is 10.2% and about 3.6 million patients were suffering from diabetes in 2017. The number of patients suffering from type 2 diabetes is 94.4% of the diabetic population.
However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Additionally, there are factors, such as the increasing focus of the major players in the emerging Asian countries and government support that is driving the growth of the wound care management device market in this region.
Tissue Engineered Skin Substitutes Industry Overview
The global Tissue Engineered Skin Substitute market is competitive and consists of very few major players. Companies like 3M Company, Amarantus BioScience Holdings, Integra LifeSciences Corporation, Molnlycke Health Care, Organogenesis Inc., Smith & Nephew plc, Stratatech Corporation, Tissue Regenix, among others, hold the substantial market share in the market.
Tissue Engineered Skin Substitutes Market Leaders
-
Amarantus BioScience Holdings
-
Organogenesis Inc.
-
3M Company
-
Smith & Nephew plc
-
Tissue Regenix
*Disclaimer: Major Players sorted in no particular order
Tissue Engineered Skin Substitutes Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Prevalence of Chronic Wounds
- 4.2.2 Growing Burn & Trauma Cases
- 4.2.3 Rising Focus on Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Lack of Feasible Reimbursement Policies
- 4.3.2 Inability of Reproducing Skin Appendages
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product type
- 5.1.1 Natural
- 5.1.2 Synthetic
-
5.2 By Application
- 5.2.1 Chronic Wounds
- 5.2.2 Acute Wounds
-
5.3 By End-User
- 5.3.1 Hospital and Clinic
- 5.3.2 Ambulatory Surgical Center
- 5.3.3 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3M Company
- 6.1.2 Amarantus BioScience Holdings
- 6.1.3 Integra LifeSciences Corporation
- 6.1.4 Molnlycke Health Care
- 6.1.5 Organogenesis Inc.
- 6.1.6 Smith & Nephew plc
- 6.1.7 Stratatech Corporation
- 6.1.8 Tissue Regenix
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityTissue Engineered Skin Substitutes Industry Segmentation
Skin substitutes are the most straightforward of the tissue-engineered organ constructs, and have been developed over many years for the testing of commercial products, therapeutics, and as models of skin biology and pathology. They are based on the ability of fibroblasts and keratinocytes to form a skin-like structure spontaneously, but have been extended by the inclusion of other cell types to provide models of the very wide range of properties displayed by intact skin. The tissue engineered skin substitute market encompasses the production of these constructs on a commercial scale, particularly for therapeutic purposes.
| By Product type | Natural | |
| Synthetic | ||
| By Application | Chronic Wounds | |
| Acute Wounds | ||
| By End-User | Hospital and Clinic | |
| Ambulatory Surgical Center | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Tissue Engineered Skin Substitutes Market Research FAQs
What is the current Tissue Engineered Skin Substitute Market size?
The Tissue Engineered Skin Substitute Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)
Who are the key players in Tissue Engineered Skin Substitute Market?
Amarantus BioScience Holdings, Organogenesis Inc. , 3M Company , Smith & Nephew plc and Tissue Regenix are the major companies operating in the Tissue Engineered Skin Substitute Market.
Which is the fastest growing region in Tissue Engineered Skin Substitute Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Tissue Engineered Skin Substitute Market?
In 2024, the North America accounts for the largest market share in Tissue Engineered Skin Substitute Market.
What years does this Tissue Engineered Skin Substitute Market cover?
The report covers the Tissue Engineered Skin Substitute Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Tissue Engineered Skin Substitute Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Tissue Engineered Skin Substitutes Industry Report
Statistics for the 2023 Tissue Engineered Skin Substitutes market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Tissue Engineered Skin Substitutes analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
